Yolo Eximcare Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
- Paid Up Capital ₹ 1.20 M
- Company Age 9 Year, 24 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.25 M
- Revenue Growth 38.13%
- Profit Growth 2523.93%
- Ebitda -715.35%
- Net Worth 50.73%
- Total Assets 9.17%
About Yolo Eximcare
Yolo Eximcare Private Limited (YEPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 January 2016 (Nine years 24 days old ). Its registered office is in Patna, Bihar, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 1.20 M.
The company currently has active open charges totaling ₹1.25 M.
Kundan Mishra and Mukesh Kumar serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909BR2016PTC025849
- Company No.
025849
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jan 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Yolo Eximcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kundan Mishra  | Additional Director | 18-Jun-2021 | Current |
| Mukesh Kumar | Director | 29-Jan-2016 | Current |
Financial Performance of Yolo Eximcare.
Yolo Eximcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 38.13% increase. The company also saw a substantial improvement in profitability, with a 2523.93% increase in profit. The company's net worth Soared by an impressive increase of 50.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yolo Eximcare?
In 2019, Yolo Eximcare had a promoter holding of 91.67% and a public holding of 8.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Edu.Med.Education To Health In Medicine Private LimitedMukesh Kumar is a mutual person
Charges (Loans)
₹1.25 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Oct 2024 | Others | ₹0.75 M | Open |
| 13 Oct 2022 | Others | ₹0.50 M | Open |
How Many Employees Work at Yolo Eximcare?
Yolo Eximcare has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yolo Eximcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yolo Eximcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
